Aurobindo Pharma: A Strong Buy Above 1165 with Target 1240
Market Desk | Super Equity
Investors looking for a solid trade setup in the pharmaceutical sector can consider Aurobindo Pharma. Based on technical analysis, the stock presents a buying opportunity above ₹1165, with a target price of ₹1240 and a stop loss at ₹1128 on a closing basis. The expected time frame for this trade is 2-3 weeks.
Technical Outlook
Aurobindo Pharma has been displaying bullish momentum, breaking key resistance levels with strong volume support. The stock has sustained its upward trend, signaling a potential move towards ₹1240. The Relative Strength Index (RSI) and Moving Averages indicate positive sentiment, reinforcing the buy recommendation.
Fundamental Factors
Strong Earnings Performance: The company has reported steady revenue growth, supported by its diversified product portfolio.
Positive Industry Trends: The pharma sector remains robust, with increased demand in domestic and international markets.
Institutional Interest: Recent accumulation by institutional investors suggests confidence in the company’s long-term prospects.
Trade Strategy
– Buy Above ₹1165
– Target Price: ₹1240
– Stop Loss: ₹1128 (Closing Basis)
– Time Frame: 2-3 Weeks
*Disclaimer
This analysis is for informational purposes only and should not be considered as investment advice. Stock market investments are subject to market risks, and past performance does not guarantee future results. Investors should conduct their own research and consult a qualified financial advisor before making any investment decisions. **Super Equity** and its affiliates are not responsible for any losses incurred due to investment actions taken based on this report.
For more stock market insights, visit [www.superequity.in](http://www.superequity.in).